- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/29 - Virus de l'hépatite
Détention brevets de la classe A61K 39/29
Brevets de cette classe: 1060
Historique des publications depuis 10 ans
|
59
|
83
|
52
|
67
|
68
|
52
|
65
|
52
|
48
|
35
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4374 |
33 |
| Glaxosmithkline Biologicals S.A. | 1653 |
31 |
| The Governors of the University of Alberta | 879 |
29 |
| Janssen Sciences Ireland Unlimited Company | 398 |
27 |
| Xiamen University | 539 |
16 |
| The Johns Hopkins University | 5731 |
14 |
| Hvidovre Hospital | 61 |
13 |
| GlobeImmune, Inc. | 77 |
12 |
| The Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 60 |
12 |
| Transgene S.A. | 127 |
12 |
| Oxford University Innovation Limited | 1566 |
11 |
| The Regents of the University of California | 20195 |
10 |
| Japan as Represented by Director-General of National Institute of Infectious Diseases | 87 |
10 |
| Tokyo Metropolitan Institute of Medical Science | 113 |
10 |
| Toko Yakuhin Kogyo Co., Ltd. | 35 |
10 |
| Toray Industries, Inc. | 7005 |
9 |
| University of Washington | 2366 |
9 |
| Variation Biotechnologies, Inc. | 66 |
9 |
| Xiamen Innovax Biotech Co., Ltd. | 92 |
9 |
| The Regents of the University of Michigan | 4759 |
8 |
| Autres propriétaires | 766 |